Nl. Poyser, EFFECTS OF ONAPRISTONE ON UTERINE PROSTAGLANDIN PRODUCTION AND PLASMAPROGESTERONE CONCENTRATIONS IN GUINEA-PIGS DURING EARLY AND MID-PREGNANCY, Journal of Reproduction and Fertility, 99(2), 1993, pp. 665-672
Onapristone (a progesterone receptor antagonist) administered to guine
a-pigs on days 11-14 of pregnancy had no effect on uterine PGF(2 alpha
) output and endometrial PGF(2 alpha) synthesizing capacity when measu
red on day 1.5. Peripheral plasma progesterone concentrations were sti
ll high on day 15, although the weight of the conceptuses was decrease
d by 50%. These findings indicate that the lack of increase in PGF(2 a
lpha) production by the uterus during early pregnancy is not due to an
inhibitory action of progesterone on uterine PGF(2 alpha) synthesis a
nd release. The output of PGF(2 alpha) from the guinea-pig uterus rema
ined low during early pregnancy, showing that the uterus is not the so
urce of increased PGF(2 alpha) secretion, as indicated previously by a
n increase in PGF(2 alpha) metabolite concentrations in the urine, aft
er day 24 of pregnancy. Of the conceptual tissues examined, the fetal
placenta had the highest PGF(2 alpha) synthesizing capacity, and it in
creased 2.3-fold between days 29 and 36 of pregnancy. The fetal placen
ta may therefore be the source of increased PGF(2 alpha) production du
ring pregnancy. Onapristone administered to guinea-pigs on days 27 and
28 or on days 34 and 35 of pregnancy resulted in the guinea-pigs bein
g in the early, middle or late stages of abortion when examined on day
s 29 or 36, respectively. Increased PG production, particularly of PGF
(2 alpha), by the uterus occurred in those guinea-pigs that were in th
e middle or late stages of abortion; uterine PG production in guinea-p
igs that were in the early stages of abortion remained low. Peripheral
concentrations of plasma progesterone remained high in guinea-pigs in
the early and middle stages of abortion but fell by 70% in those guin
ea-pigs in the late stages of abortion. These results indicate that in
creased uterine PG production following onapristone treatment in mid-p
regnancy occurs as a result of the abortion process and is not respons
ible for the initiation of pregnancy termination.